182 related articles for article (PubMed ID: 32556455)
1. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
Rearigh L; Stohs E; Freifeld A; Zimmer A
Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Kroll AL; Corrigan PA; Patel S; Hawks KG
J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
[TBL] [Abstract][Full Text] [Related]
5. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
[No Abstract] [Full Text] [Related]
6. De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period.
Gustinetti G; Raiola AM; Varaldo R; Galaverna F; Gualandi F; Del Bono V; Bacigalupo A; Angelucci E; Viscoli C; Mikulska M
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1721-1726. PubMed ID: 29578073
[TBL] [Abstract][Full Text] [Related]
7. Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies.
Stohs EJ; Abbas A; Freifeld A
Transpl Infect Dis; 2024 Apr; 26(2):e14236. PubMed ID: 38349035
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
[TBL] [Abstract][Full Text] [Related]
10. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
[No Abstract] [Full Text] [Related]
11. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
[TBL] [Abstract][Full Text] [Related]
12. The use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplants.
Hamadah A; Schreiber Y; Toye B; McDiarmid S; Huebsch L; Bredeson C; Tay J
PLoS One; 2012; 7(9):e46220. PubMed ID: 23029441
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?
Butters C; Thursky K; Hanna DT; Cole T; Davidson A; Buttery J; Haeusler G
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):267-279. PubMed ID: 36694289
[TBL] [Abstract][Full Text] [Related]
14. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
15. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
[TBL] [Abstract][Full Text] [Related]
16. A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G; Kaynar L; Yozgat N; Elmali F; Kürkçüoglu CA; Alp E; Çetin M
Infez Med; 2017 Mar; 25(1):33-37. PubMed ID: 28353453
[TBL] [Abstract][Full Text] [Related]
17. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
[TBL] [Abstract][Full Text] [Related]
18. The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Perreault S; McManus D; Bar N; Foss F; Gowda L; Isufi I; Seropian S; Malinis M; Topal JE
Transpl Infect Dis; 2019 Apr; 21(2):e13059. PubMed ID: 30737868
[TBL] [Abstract][Full Text] [Related]
19. Empiric use of linezolid in febrile hematology and hematopoietic stem cell transplantation patients colonized with vancomycin-resistant Enterococcus spp.
Lisboa LF; Miranda BG; Vieira MB; Dulley FL; Fonseca GG; Guimarães T; Levin AS; Shikanai-Yasuda MA; Costa SF
Int J Infect Dis; 2015 Apr; 33():171-6. PubMed ID: 25660090
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
